Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread

por Bull, Maireid B., Cohen, Carolyn A., Leung, Nancy H.L., Valkenburg, Sophie A.
Publicado 2021

T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants

por Nguyen, Thi H. O., Cohen, Carolyn A., Rowntree, Louise C., Bull, Maireid B., Hachim, Asmaa, Kedzierska, Katherine, Valkenburg, Sophie A.
Publicado 2021

Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults

por Kavian, Niloufar, Hachim, Asmaa, Li, Athena PY, Cohen, Carolyn A, Chin, Alex WH, Poon, Leo LM, Fang, Vicky J, Leung, Nancy HL, Cowling, Benjamin J, Valkenburg, Sophie A
Publicado 2020

Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection

por Hachim, Asmaa, Kavian, Niloufar, Cohen, Carolyn A., Chin, Alex W. H., Chu, Daniel K. W., Mok, Chris K. P., Tsang, Owen T. Y., Yeung, Yiu Cheong, Perera, Ranawaka A. P. M., Poon, Leo L. M., Peiris, J. S. Malik, Valkenburg, Sophie A.
Publicado 2020

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection

por Cohen, Carolyn A, Li, Athena PY, Hachim, Asmaa, Hui, David SC, Kwan, Mike YW, Tsang, Owen TY, Chiu, Susan S, Chan, Wai Hung, Yau, Yat Sun, Kavian, Niloufar, Ma, Fionn NL, Lau, Eric HY, Cheng, Samuel MS, Poon, Leo LM, Peiris, JS Malik, Valkenburg, Sophie A
Publicado 2021

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults

por Li, Athena P. Y., Cohen, Carolyn A., Leung, Nancy H. L., Fang, Vicky J., Gangappa, Shivaprakash, Sambhara, Suryaprakash, Levine, Min Z., Iuliano, A. Danielle, Perera, Ranawaka A. P. M., Ip, Dennis K. M., Peiris, J. S. Malik, Thompson, Mark G., Cowling, Benjamin J., Valkenburg, Sophie A.
Publicado 2021

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection

por Cohen, Carolyn A., Li, Athena P. Y., Hachim, Asmaa, Hui, David S. C., Kwan, Mike Y. W., Tsang, Owen T. Y., Chiu, Susan S., Chan, Wai Hung, Yau, Yat Sun, Kavian, Niloufar, Ma, Fionn N. L., Lau, Eric H. Y., Cheng, Samuel M. S., Poon, Leo L. M., Peiris, Malik, Valkenburg, Sophie A.
Publicado 2021

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong

por Mok, Chris Ka Pun, Cohen, Carolyn A., Cheng, Samuel M. S., Chen, Chunke, Kwok, Kin‐On, Yiu, Karen, Chan, Tat‐On, Bull, Maireid, Ling, Kwun Cheung, Dai, Zixi, Ng, Susanna S., Lui, Grace Chung‐Yan, Wu, Chao, Amarasinghe, Gaya K., Leung, Daisy W., Wong, Samuel Yeung Shan, Valkenburg, Sophie A., Peiris, Malik, Hui, David S.
Publicado 2021

Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents

por Leung, Daniel, Cohen, Carolyn A., Mu, Xiaofeng, Rosa Duque, Jaime S., Cheng, Samuel M. S., Wang, Xiwei, Wang, Manni, Zhang, Wenyue, Zhang, Yanmei, Tam, Issan Y. S., Lam, Jennifer H. Y., Chan, Sau Man, Chaothai, Sara, Kwan, Kelvin K. H., Chan, Karl C. K., Li, John K. C., Luk, Leo L. H., Tsang, Leo C. H., Chu, Nym Coco, Wong, Wilfred H. S., Mori, Masashi, Leung, Wing Hang, Valkenburg, Sophie, Peiris, Malik, Tu, Wenwei, Lau, Yu Lung
Publicado 2023

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label,...

por Leung, Nancy H L, Cheng, Samuel M S, Cohen, Carolyn A, Martín-Sánchez, Mario, Au, Niki Y M, Luk, Leo L H, Tsang, Leo C H, Kwan, Kelvin K H, Chaothai, Sara, Fung, Lison W C, Cheung, Alan W L, Chan, Karl C K, Li, John K C, Ng, Yvonne Y, Kaewpreedee, Prathanporn, Jia, Janice Z, Ip, Dennis K M, Poon, Leo L M, Leung, Gabriel M, Peiris, J S Malik, Valkenburg, Sophie A, Cowling, Benjamin J
Publicado 2023

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

por Rosa Duque, Jaime S., Wang, Xiwei, Leung, Daniel, Cheng, Samuel M. S., Cohen, Carolyn A., Mu, Xiaofeng, Hachim, Asmaa, Zhang, Yanmei, Chan, Sau Man, Chaothai, Sara, Kwan, Kelvin K. H., Chan, Karl C. K., Li, John K. C., Luk, Leo L. H., Tsang, Leo C. H., Wong, Wilfred H. S., Cheang, Cheuk Hei, Hung, Timothy K., Lam, Jennifer H. Y., Chua, Gilbert T., Tso, Winnie W. Y., Ip, Patrick, Mori, Masashi, Kavian, Niloufar, Leung, Wing Hang, Valkenburg, Sophie, Peiris, Malik, Tu, Wenwei, Lau, Yu Lung
Publicado 2022

Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

por Rosa Duque, Jaime S., Wang, Xiwei, Leung, Daniel, Cheng, Samuel M. S., Cohen, Carolyn A., Mu, Xiaofeng, Hachim, Asmaa, Zhang, Yanmei, Chan, Sau Man, Chaothai, Sara, Kwan, Kelvin K. H., Chan, Karl C. K., Li, John K. C., Luk, Leo L. H., Tsang, Leo C. H., Wong, Wilfred H. S., Cheang, Cheuk Hei, Hung, Timothy K., Lam, Jennifer H. Y., Chua, Gilbert T., Tso, Winnie W. Y., Ip, Patrick, Mori, Masashi, Kavian, Niloufar, Leung, Wing Hang, Valkenburg, Sophie, Peiris, Malik, Tu, Wenwei, Lau, Yu Lung
Publicado 2022

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents

por Mu, Xiaofeng, Cohen, Carolyn A., Leung, Daniel, Rosa Duque, Jaime S., Cheng, Samuel M. S., Chung, Yuet, Wong, Howard H. W., Lee, Amos M. T., Li, Wing Yan, Tam, Issan Y. S., Lam, Jennifer H. Y., Lee, Derek H. L., Chan, Sau Man, Tsang, Leo C. H., Chan, Karl C. K., Li, John K. C., Luk, Leo L. H., Chaothai, Sara, Kwan, Kelvin K. H., Chu, Nym Coco, Mori, Masashi, Jeevan, Trushar, Kandeil, Ahmed, Webby, Richard J., Tu, Wenwei, Valkenburg, Sophie A., Peiris, Malik, Lau, Yu Lung
Publicado 2022